Alpha-Melanocyte-Stimulating Hormone

Overview

Alpha-melanocyte-stimulating hormone (alpha-MSH) is a tridecapeptide derived from the precursor protein proopiomelanocortin (POMC). POMC is a complex polyprotein expressed in the anterior and intermediate lobes of the pituitary gland, as well as in hypothalamic neurons, skin keratinocytes, and immune cells. Tissue-specific post-translational processing by prohormone convertases yields distinct peptide products, including ACTH, beta-MSH, beta-endorphin, and the melanocortin peptides.

Structure

Alpha-MSH is a 13-amino acid peptide with the sequence Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2. The N-terminal serine is acetylated, a modification that protects the peptide from aminopeptidase degradation and significantly increases its biological half-life and potency. The conserved His-Phe-Arg-Trp core motif is essential for melanocortin receptor binding and activation.

Melanocortin Receptor System

Alpha-MSH signals through melanocortin receptors (MCRs), a family of five G-protein-coupled receptors:

• MC1R: Expressed on melanocytes, mediating eumelanin synthesis. Alpha-MSH binding stimulates tyrosinase activity, increasing melanin production and darker pigmentation.
• MC2R: The ACTH receptor, primarily expressed in the adrenal cortex.
• MC3R: Expressed in the hypothalamus and gastrointestinal tract, playing a role in energy homeostasis and feeding behavior.
• MC4R: Expressed in the hypothalamus, brainstem, and peripheral tissues. MC4R mediates the anorexigenic effects of alpha-MSH and is critical for energy balance regulation.
• MC5R: Expressed in exocrine glands and adipose tissue.

The melanocortin system is regulated by the endogenous antagonist Agouti-related peptide (AgRP), which is co-expressed with NPY in arcuate nucleus neurons. AgRP competitively inhibits alpha-MSH at MC3R and MC4R, creating an orexigenic counterbalance.

Physiological Functions

In the skin, alpha-MSH is a principal mediator of tanning responses to ultraviolet radiation, acting through MC1R on epidermal melanocytes. In the hypothalamus, alpha-MSH released from POMC neurons activates MC4R to suppress appetite and increase energy expenditure. Loss-of-function mutations in the POMC gene or MC4R gene cause severe early-onset obesity, with MC4R mutations being the most common monogenic cause of obesity in humans.

Clinical Applications

Setmelanotide, a selective MC4R agonist, has been approved for the treatment of obesity associated with POMC, PCSK1, or LEPR deficiency, and for Bardet-Biedl syndrome. This represents a precision medicine approach targeting the melanocortin pathway for genetically defined obesity subtypes.